NCT00131300View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2004

Study Completion Date

February 28, 2006

Conditions
OsteoarthritisMusculoskeletal Diseases
Interventions
DEVICE

Synvisc (hylan G-F 20)

Trial Locations (6)

32545

August-Viktoria-Klinik, Bad Oeynhausen

33700

Centre de Medecine et Traumatologie du Sport Clinique du Sport, Mérignac

37044

CHRU Hopital Trousseau, Tours

69003

Clinique Saint Anne Lumiere, Lyon

92100

Hopital Ambroise Pare, Boulogne-Billancourt

06097

Universitatsklinik und Poliklinik Orthopadie & Physikalische Medizin, Halle

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00131300 - A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis | Biotech Hunter | Biotech Hunter